Nutritional supplement: NADH to possibly treat Alzheimer's and Chronic Fatigue Syndrome

NADH, a naturally-occurring coenzyme, shows promise in increasing cognitive function and energy levels.


| November/December 1997


NADH shows promisefor Parkinson’s, CFS, Alzheimer’s 

Preliminary research on NADH, a coenzyme found in all living cells, shows that it may help treat some degenerative diseases and chronic fatigue syndrome.

Building on studies conducted by European researcher Dr. Georg Birkmayer, researchers at Georgetown University Medical Center began two double-blind human trials in 1996 testing Birkmayer’s patented form of NADH (nicotinamide adenine dinucleotide), marketed as Enada. The Georgetown trials focus on Alzheimer’s disease and chronic fatigue syndrome (cfs) and, so far, are encouraging, according to a Georgetown press release. Study results could be complete by late 1997 and 1998.

The trials have been approved by the U.S. Food and Drug Administration (FDA) through the Investigational New Drug process, which allows the FDA to stop trials of promising but unknown drugs if they appear to be dangerous to human health, according to Arthur Whitmore, an FDA spokesman. The process doesn’t indicate FDA approval of Enada’s use as a drug.

The research behind NADH

Georg Birkmayer, a medical doctor who has studied NADH since the mid-1980s, has published the results of many of his pilot studies on NADH. Birkmayer is director of the Birkmayer Institute for Parkinson Ther­apy in Vienna, Austria, and of the neurochemistry division at the University of Graz, Austria. He also is the secretary general of the International Academy of Tumor Marker Oncology and the European editor of the Journal of Tumor Marker Oncology.

During the early 1960s, Georg Birkmayer’s father, Waltham Birkmayer, researched L-dopa as a treatment for Parkinson’s disease. L-dopa is sold as the drug Sinemet, but it isn’t effective for all Parkinson’s patients after long-term use.

Because of that, the Birkmayers tested NADH on 470 Parkinson’s patients. According to their published research, the treatment improved symptoms for the study participants. The Birkmayers subsequently developed Enada, a stabilized, enteric-coated form of NADH that can be taken orally.





mother earth news fair 2018 schedule

MOTHER EARTH NEWS FAIR

Next: June 2-3, 2018
Frederick, MD

Sit in on dozens of practical workshops from the leading authorities on natural health, organic gardening, real food and more!

LEARN MORE



Subscribe today and save 58%

Subscribe to Mother Earth Living !

Mother Earth LivingWelcome to Mother Earth Living, the authority on green lifestyle and design. Each issue of Mother Earth Living features advice to create naturally healthy and nontoxic homes for yourself and your loved ones. With Mother Earth Living by your side, you’ll discover all the best and latest information you want on choosing natural remedies and practicing preventive medicine; cooking with a nutritious and whole-food focus; creating a nontoxic home; and gardening for food, wellness and enjoyment. Subscribe to Mother Earth Living today to get inspired on the art of living wisely and living well.

Save Money & a Few Trees!

Pay now with a credit card and take advantage of our earth-friendly automatic renewal savings plan. You’ll save an additional $5 and get six issues of Mother Earth Living for just $19.95! (Offer valid only in the U.S.)

Or, choose Bill Me and pay just $24.95.




Facebook Pinterest Instagram YouTube Twitter


Copyright 2018, All Rights Reserved
Ogden Publications, Inc., 1503 SW 42nd St., Topeka, Kansas 66609-1265